These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 37033892)

  • 1. Identification and treatment of individuals with attention-deficit/hyperactivity disorder and substance use disorder: An expert consensus statement.
    Young S; Abbasian C; Al-Attar Z; Branney P; Colley B; Cortese S; Cubbin S; Deeley Q; Gudjonsson GH; Hill P; Hollingdale J; Jenden S; Johnson J; Judge D; Lewis A; Mason P; Mukherjee R; Nutt D; Roberts J; Robinson F; Woodhouse E; Cocallis K
    World J Psychiatry; 2023 Mar; 13(3):84-112. PubMed ID: 37033892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guidance for identification and treatment of individuals with attention deficit/hyperactivity disorder and autism spectrum disorder based upon expert consensus.
    Young S; Hollingdale J; Absoud M; Bolton P; Branney P; Colley W; Craze E; Dave M; Deeley Q; Farrag E; Gudjonsson G; Hill P; Liang HL; Murphy C; Mackintosh P; Murin M; O'Regan F; Ougrin D; Rios P; Stover N; Taylor E; Woodhouse E
    BMC Med; 2020 May; 18(1):146. PubMed ID: 32448170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [International Consensus Statement for the Screening, Diagnosis, and Treatment of Adolescents with Concurrent Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder].
    Özgen H; Spijkerman R; Noack M; Holtmann M; Schellekens ASA; van de Glind G; Banaschewski T; Barta C; Begeman A; Casas M; Crunelle CL; Daigre Blanco C; Dalsgaard S; Demetrovics Z; den Boer J; Dom G; Eapen V; Faraone SV; Franck J; González RA; Grau-López L; Groenman AP; Hemphälä M; Icick R; Johnson B; Kaess M; Kapitány-Fövény M; Kasinathan JG; Kaye SS; Kiefer F; Konstenius M; Levin FR; Luderer M; Martinotti G; Matthys FIA; Meszaros G; Moggi F; Munasur-Naidoo AP; Post M; Rabinovitz S; Ramos-Quiroga JA; Sala R; Shafi A; Slobodin O; Staal WG; Thomasius R; Truter I; van Kernebeek MW; Velez-Pastrana MC; Vollstädt-Klein S; Vorspan F; Young JT; Yule A; van den Brink W; Hendriks V
    Z Kinder Jugendpsychiatr Psychother; 2021 Jan; 50(1):54-67. PubMed ID: 34397296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. International Consensus Statement for the Screening, Diagnosis, and Treatment of Adolescents with Concurrent Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder.
    Özgen H; Spijkerman R; Noack M; Holtmann M; Schellekens ASA; van de Glind G; Banaschewski T; Barta C; Begeman A; Casas M; Crunelle CL; Daigre Blanco C; Dalsgaard S; Demetrovics Z; den Boer J; Dom G; Eapen V; Faraone SV; Franck J; González RA; Grau-López L; Groenman AP; Hemphälä M; Icick R; Johnson B; Kaess M; Kapitány-Fövény M; Kasinathan JG; Kaye SS; Kiefer F; Konstenius M; Levin FR; Luderer M; Martinotti G; Matthys FIA; Meszaros G; Moggi F; Munasur-Naidoo AP; Post M; Rabinovitz S; Ramos-Quiroga JA; Sala R; Shafi A; Slobodin O; Staal WG; Thomasius R; Truter I; van Kernebeek MW; Velez-Pastrana MC; Vollstädt-Klein S; Vorspan F; Young JT; Yule A; van den Brink W; Hendriks V
    Eur Addict Res; 2020; 26(4-5):223-232. PubMed ID: 32634814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Females with ADHD: An expert consensus statement taking a lifespan approach providing guidance for the identification and treatment of attention-deficit/ hyperactivity disorder in girls and women.
    Young S; Adamo N; Ásgeirsdóttir BB; Branney P; Beckett M; Colley W; Cubbin S; Deeley Q; Farrag E; Gudjonsson G; Hill P; Hollingdale J; Kilic O; Lloyd T; Mason P; Paliokosta E; Perecherla S; Sedgwick J; Skirrow C; Tierney K; van Rensburg K; Woodhouse E
    BMC Psychiatry; 2020 Aug; 20(1):404. PubMed ID: 32787804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and treatment of offenders with attention-deficit/hyperactivity disorder in the prison population: a practical approach based upon expert consensus.
    Young S; Gudjonsson G; Chitsabesan P; Colley B; Farrag E; Forrester A; Hollingdale J; Kim K; Lewis A; Maginn S; Mason P; Ryan S; Smith J; Woodhouse E; Asherson P
    BMC Psychiatry; 2018 Sep; 18(1):281. PubMed ID: 30180832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Adolescents with concurrent ADHD and substance use disorder; international consensus].
    Spijkerman R; Crunelle CL; Özgen MH; Begeman AHA; Dom G; van de Glind G; Groenman AP; van Kernebeek MW; Matthys F; Post M; Schellekens A; Staal W; van den Brink W; Hendriks VM
    Tijdschr Psychiatr; 2021; 63(12):868-874. PubMed ID: 34978058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guidelines for identification and treatment of individuals with attention deficit/hyperactivity disorder and associated fetal alcohol spectrum disorders based upon expert consensus.
    Young S; Absoud M; Blackburn C; Branney P; Colley B; Farrag E; Fleisher S; Gregory G; Gudjonsson GH; Kim K; O'Malley KD; Plant M; Rodriguez A; Ozer S; Takon I; Woodhouse E; Mukherjee R
    BMC Psychiatry; 2016 Sep; 16(1):324. PubMed ID: 27655132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment and treatment of substance use in adults with ADHD: a psychological approach.
    Young S; Woodhouse E
    J Neural Transm (Vienna); 2021 Jul; 128(7):1099-1108. PubMed ID: 33211196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. International Consensus Statement on Screening, Diagnosis and Treatment of Substance Use Disorder Patients with Comorbid Attention Deficit/Hyperactivity Disorder.
    Crunelle CL; van den Brink W; Moggi F; Konstenius M; Franck J; Levin FR; van de Glind G; Demetrovics Z; Coetzee C; Luderer M; Schellekens A; ; Matthys F
    Eur Addict Res; 2018; 24(1):43-51. PubMed ID: 29510390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screened Attention Deficit/Hyperactivity Disorder as a Predictor of Substance Use Initiation and Escalation in Early Adulthood and the Role of Self-Reported Conduct Disorder and Sensation Seeking: A 5-Year Longitudinal Study with Young Adult Swiss Men.
    Moggi F; Schorno D; Soravia LM; Mohler-Kuo M; Estévez-Lamorte N; Studer J; Gmel G
    Eur Addict Res; 2020; 26(4-5):233-244. PubMed ID: 32564034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential Diagnosis in Patients with Substance Use Disorder and/or Attention-Deficit/Hyperactivity Disorder Using Continuous Performance Test.
    Slobodin O; Blankers M; Kapitány-Fövény M; Kaye S; Berger I; Johnson B; Demetrovics Z; van den Brink W; van de Glind G
    Eur Addict Res; 2020; 26(3):151-162. PubMed ID: 32074617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attention deficit/hyperactivity disorders with co-existing substance use disorder is characterized by early antisocial behaviour and poor cognitive skills.
    Bihlar Muld B; Jokinen J; Bölte S; Hirvikoski T
    BMC Psychiatry; 2013 Dec; 13():336. PubMed ID: 24330331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Substance Misuse and Family History of Substance Use Disorder on Delay Discounting in Adolescents and Young Adults with Attention-Deficit/Hyperactivity Disorder.
    Paraskevopoulou M; van Rooij D; Schene AH; Scheres APJ; Buitelaar JK; Schellekens AFA
    Eur Addict Res; 2020; 26(4-5):295-305. PubMed ID: 32659779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. University students with attention deficit hyperactivity disorder (ADHD): a consensus statement from the UK Adult ADHD Network (UKAAN).
    Sedgwick-Müller JA; Müller-Sedgwick U; Adamou M; Catani M; Champ R; Gudjónsson G; Hank D; Pitts M; Young S; Asherson P
    BMC Psychiatry; 2022 Apr; 22(1):292. PubMed ID: 35459116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The complicated relationship between attention deficit/hyperactivity disorder and substance use disorders.
    Zulauf CA; Sprich SE; Safren SA; Wilens TE
    Curr Psychiatry Rep; 2014 Mar; 16(3):436. PubMed ID: 24526271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adult attention-deficit/hyperactivity disorder and its association with substance use and substance use disorders in young men.
    Estévez N; Dey M; Eich-Höchli D; Foster S; Gmel G; Mohler-Kuo M
    Epidemiol Psychiatr Sci; 2016 Jun; 25(3):255-66. PubMed ID: 25989844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [International consensus for the screening, diagnosis and treatment of adult patients with substance use disorder and ADHD].
    Crunelle CL; van den Brink W; Schellekens A; van de Glind G; Icasa Consortium B; Matthys F
    Tijdschr Psychiatr; 2019; 61(7):477-487. PubMed ID: 31372969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of substance misuse and current family history of substance use disorder on brain structure in adolescents and young adults with attention-deficit/hyperactivity disorder.
    Novi M; Paraskevopoulou M; Van Rooij D; Schene AH; Buitelaar JK; Schellekens AFA
    Drug Alcohol Depend; 2021 Nov; 228():109032. PubMed ID: 34555690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.